With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.
A solution of 4,7-diphenyl-1,10-phenanthroline (0.36 g, 1.10 mmol) in methanol (10 ml) was added to a solution of TlCl3*4H2O (0.42 g, 1.10 mmol) in methanol (10 ml) and the resulting colorless solution was stirred for 20 min at 40C. Suitable crystals for the X-ray diffraction measurement were obtained by methanol diffusion to a colorless solution of 1 in DMSO over two weeks (yield 0.60 g, 75.6%, m.p. > 300C). IR (CsI, cm-1): 3060 m, 2921 m, 2854 w, 1611 m, 1563 m, 1510 m, 1433 s, 1365 s, 1275 w, 1234 m, 1098 m, 1010 s, 941 m, 849 s, 759 s, 700 s, 626 w, 554 m, 491 w, 420 m, 339 m, 262 m. UV-Vis: lambdamax (DMSO, nm), 315. Anal. calcd. (%): C 43.29, H 3.05, N 3.88. Found (%): C 43.01, H 3.03, N 3.85.
The synthetic route of 1662-01-7 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Ghadermazi; Journal of Structural Chemistry; vol. 57; 5; (2016); p. 970 – 975; Zh. Strukt. Kim.; vol. 57; 5; (2016); p. 1020 – 1025,6;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI